Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Emini

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
The Journal of Biological Chemistry|February 11, 1994
Viral long terminal repeat substrate binding characteristics of the human immunodeficiency virus type 1 integraseD J Hazuda, A L Wolfe, J C Hastings, et al.
Molecular Pharmacology|July 1, 1990
Inhibition of human immunodeficiency virus-1 reverse transcriptase activity by rubromycins: competitive interaction at the template.primer siteM E Goldman, G S Salituro, J A Bowen, et al.
Journal of Virology|December 1, 1992
Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibodyM K Gorny, A J Conley, S Karwowska, et al.
Gene|January 1, 1987
Expression and secretion in yeast of a 400-kDa envelope glycoprotein derived from Epstein-Barr virusL D Schultz, J Tanner, K J Hofmann, et al.
The Journal of Biological Chemistry|May 20, 1994
Peptide substrate cleavage specificity of the human cytomegalovirus proteaseV V Sardana, J A Wolfgang, C A Veloski, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1995
Inhibition of human immunodeficiency virus integrase by bis-catecholsR L LaFemina, P L Graham, K LeGrow, et al.
Journal of Virology|December 1, 1992
Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cellsR L LaFemina, C L Schneider, H L Robbins, et al.
International Journal of Peptide and Protein Research|May 1, 1993
Cyclic V3-loop-related HIV-1 conjugate vaccines. Synthesis, conformation and immunological propertiesR L Tolman, M A Bednarek, B A Johnson, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1992
Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitorsJ H Condra, E A Emini, L Gotlib, et al.
Antiviral Research|April 1, 1995
Molecular mechanisms of antiviral resistanceD W Kimberlin, D M Coen, K K Biron, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
The Journal of Biological Chemistry|February 11, 1994
Viral long terminal repeat substrate binding characteristics of the human immunodeficiency virus type 1 integraseD J Hazuda, A L Wolfe, J C Hastings, et al.
Molecular Pharmacology|July 1, 1990
Inhibition of human immunodeficiency virus-1 reverse transcriptase activity by rubromycins: competitive interaction at the template.primer siteM E Goldman, G S Salituro, J A Bowen, et al.
Journal of Virology|December 1, 1992
Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibodyM K Gorny, A J Conley, S Karwowska, et al.
Gene|January 1, 1987
Expression and secretion in yeast of a 400-kDa envelope glycoprotein derived from Epstein-Barr virusL D Schultz, J Tanner, K J Hofmann, et al.
The Journal of Biological Chemistry|May 20, 1994
Peptide substrate cleavage specificity of the human cytomegalovirus proteaseV V Sardana, J A Wolfgang, C A Veloski, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1995
Inhibition of human immunodeficiency virus integrase by bis-catecholsR L LaFemina, P L Graham, K LeGrow, et al.
Journal of Virology|December 1, 1992
Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cellsR L LaFemina, C L Schneider, H L Robbins, et al.
International Journal of Peptide and Protein Research|May 1, 1993
Cyclic V3-loop-related HIV-1 conjugate vaccines. Synthesis, conformation and immunological propertiesR L Tolman, M A Bednarek, B A Johnson, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1992
Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitorsJ H Condra, E A Emini, L Gotlib, et al.
Antiviral Research|April 1, 1995
Molecular mechanisms of antiviral resistanceD W Kimberlin, D M Coen, K K Biron, et al.
Pageof 10